142 related articles for article (PubMed ID: 22133320)
1. Drug-induced epidermal necrolysis: Important new piece to end the puzzle.
Roujeau JC; Bricard G; Nicolas JF
J Allergy Clin Immunol; 2011 Dec; 128(6):1277-8. PubMed ID: 22133320
[No Abstract] [Full Text] [Related]
2. T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction.
Ko TM; Chen YT
Expert Rev Clin Immunol; 2012 Jul; 8(5):467-77. PubMed ID: 22882221
[TBL] [Abstract][Full Text] [Related]
3. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.
Ko TM; Chung WH; Wei CY; Shih HY; Chen JK; Lin CH; Chen YT; Hung SI
J Allergy Clin Immunol; 2011 Dec; 128(6):1266-1276.e11. PubMed ID: 21924464
[TBL] [Abstract][Full Text] [Related]
4. Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.
Wei CY; Chung WH; Huang HW; Chen YT; Hung SI
J Allergy Clin Immunol; 2012 Jun; 129(6):1562-9.e5. PubMed ID: 22322005
[TBL] [Abstract][Full Text] [Related]
5. Oxcarbazepine-induced Stevens-Johnson syndrome in a patient with HLA-B*1502 genotype.
Chen YC; Chu CY; Hsiao CH
J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):702-3. PubMed ID: 18785891
[No Abstract] [Full Text] [Related]
6. Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.
Chung WH; Hung SI
Allergol Int; 2010 Dec; 59(4):325-32. PubMed ID: 20962567
[TBL] [Abstract][Full Text] [Related]
7. Carbamazepine Induces Focused T Cell Responses in Resolved Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Cases But Does Not Perturb the Immunopeptidome for T Cell Recognition.
Mifsud NA; Illing PT; Lai JW; Fettke H; Hensen L; Huang Z; Rossjohn J; Vivian JP; Kwan P; Purcell AW
Front Immunol; 2021; 12():653710. PubMed ID: 33912179
[TBL] [Abstract][Full Text] [Related]
8. Oxcarbazepine-induced Stevens-Johnson syndrome: a case report.
Lin LC; Lai PC; Yang SF; Yang RC
Kaohsiung J Med Sci; 2009 Feb; 25(2):82-6. PubMed ID: 19321411
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
[TBL] [Abstract][Full Text] [Related]
10. Stratification of the risk of serious allergic cutaneous reactions with therapeutic management of trigeminal neuralgia.
Shakib K; Sinanan M
Br J Oral Maxillofac Surg; 2011 Apr; 49(3):235-6. PubMed ID: 20430493
[TBL] [Abstract][Full Text] [Related]
11. Structural modeling of HLA-B*1502/peptide/carbamazepine/T-cell receptor complex architecture: implication for the molecular mechanism of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
Zhou P; Zhang S; Wang Y; Yang C; Huang J
J Biomol Struct Dyn; 2016 Aug; 34(8):1806-17. PubMed ID: 26488421
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigens and drug hypersensitivity.
Chung WH; Hung SI; Chen YT
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
[TBL] [Abstract][Full Text] [Related]
13. HLA alleles and drug hypersensitivity reactions.
Profaizer T; Eckels D
Int J Immunogenet; 2012 Apr; 39(2):99-105. PubMed ID: 22136512
[TBL] [Abstract][Full Text] [Related]
14. HLA-B*1502-bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome.
Yang CW; Hung SI; Juo CG; Lin YP; Fang WH; Lu IH; Chen ST; Chen YT
J Allergy Clin Immunol; 2007 Oct; 120(4):870-7. PubMed ID: 17697703
[TBL] [Abstract][Full Text] [Related]
15. HLA-B allele associations with certain drugs are not confirmed in Japanese patients with severe cutaneous drug reactions.
Kano Y; Hirahara K; Asano Y; Shiohara T
Acta Derm Venereol; 2008; 88(6):616-8. PubMed ID: 19002350
[No Abstract] [Full Text] [Related]
16. Severe bullous hypersensitivity reactions after exposure to carbamazepine in a Han-Chinese child with a positive HLA-B*1502 and negative in vitro toxicity assays: evidence for different pathophysiological mechanisms.
Elzagallaai AA; Garcia-Bournissen F; Finkelstein Y; Bend JR; Rieder MJ; Koren G
J Popul Ther Clin Pharmacol; 2011; 18(1):e1-9. PubMed ID: 21289376
[TBL] [Abstract][Full Text] [Related]
17. Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: what causes the diversity?
Dainichi T; Uchi H; Moroi Y; Furue M
Dermatology; 2007; 215(1):86-8. PubMed ID: 17587850
[No Abstract] [Full Text] [Related]
18. Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations.
Ferrell PB; McLeod HL
Pharmacogenomics; 2008 Oct; 9(10):1543-6. PubMed ID: 18855540
[TBL] [Abstract][Full Text] [Related]
19. Association of carbamazepine-induced severe cutaneous drug reactions and HLA-B*1502 allele status, and dose and treatment duration in paediatric neurology patients in Singapore.
Chong KW; Chan DW; Cheung YB; Ching LK; Hie SL; Thomas T; Ling S; Tan EC
Arch Dis Child; 2014 Jun; 99(6):581-4. PubMed ID: 24225276
[TBL] [Abstract][Full Text] [Related]
20. New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity.
Michels AW; Ostrov DA
J Allergy Clin Immunol; 2015 Aug; 136(2):252-7. PubMed ID: 26254052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
